Idiopathic dilated cardiomyopathy

Catherine E. Cooke, Michael D. Greenberg, Steven S. Coughlin, Kenneth Mishark, Masato Odawara, Kamejiro Yamashita, Sewa S. Legha, G. W. Dec, Valentin Fuster

Research output: Contribution to journalLetter

5 Scopus citations

Abstract

To the Editor: Dec and Fuster (Dec. 8 issue)1 categorized the use of beta-blockers in patients with idiopathic dilated cardiomyopathy as investigational. There is now sufficient evidence to support their use as adjunctive therapy. Numerous clinical trials have evaluated the use of beta-blockers in conjunction with angiotensin-converting—enzyme inhibitors, nitrates, diuretics, and digoxin in patients with idiopathic dilated cardiomyopathy and have found improvements in ejection fraction, cardiac index, and New York Heart Association class and a decreased number of hospital admissions and cardiac transplantations.24 However, there have been trials5,6 that did not show such improvements. This is probably because.

Original languageEnglish (US)
Pages (from-to)1384-1386
Number of pages3
JournalNew England Journal of Medicine
Volume332
Issue number20
DOIs
StatePublished - May 18 1995
Externally publishedYes

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint Dive into the research topics of 'Idiopathic dilated cardiomyopathy'. Together they form a unique fingerprint.

  • Cite this

    Cooke, C. E., Greenberg, M. D., Coughlin, S. S., Mishark, K., Odawara, M., Yamashita, K., Legha, S. S., Dec, G. W., & Fuster, V. (1995). Idiopathic dilated cardiomyopathy. New England Journal of Medicine, 332(20), 1384-1386. https://doi.org/10.1056/NEJM199505183322015